Firma BellaSeno, Autor bei Presse-Blog

BellaSeno Starts Two Clinical Trials of its Resorbable Breast and Chest Implants

4. August 2022 Firma BellaSenoMedizintechnikabsorbable, bellaseno, breast, cancer, excavatum, forsoft, hbi, implant, implants, patients, pectus, scaffold, senella, suture, with

Resorbable implants to treat pectus excavatum and silicone breast implant revision / congenital defect correction First patients treated in Australia BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, today announced the start of Mehr

BellaSeno Announces Publication of First-in-Human Data of its Lead Program Senella

8. Dezember 2021 Firma BellaSenoMedizintechnikabsorbable, bellaseno, bellasenos, breast, clinical, excavatum, graft, implant, implants, medtech, patients, pectus, scaffold, senella, with

Successful initial treatment of pectus excavatum patient in Australia Data published in the European Journal of Plastic Surgery confirms Bellaseno’s novel approach in soft tissue engineering BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, Mehr

BellaSeno Appoints Tobias Grossner to Chief Medical Officer

2. Dezember 20212. Dezember 2021 Firma BellaSenoMedizintechnikabsorbable, bellaseno, bone, breast, clinical, fraunhofer, grossner, heidelberg, implant, implants, patients, research, scaffold, senella, with

BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced the appointment of Dr. med. Tobias Grossner as Chief Medical Officer (CMO). Dr. Grossner brings strong clinical expertise in trauma surgery and regenerative medicine Mehr

BellaSeno Receives Australian Public Grant Totaling AUD 1 Million

15. September 202115. September 2021 Firma BellaSenoFirmeninternabsorbable, bellaseno, bone, breast, cancer, chhaya, evonik, honor, implant, implants, market, patients, scaffold, senella, with

Winner of the Australian Global Innovation Linkages Program Funding dedicated to advancing regenerative scaffolds for breast reconstruction and large bone defects BellaSeno to lead consortium of renowned commercial and academic partners BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable Mehr

BellaSeno Initiates Scaffold Development Program for Tendon and Ligament Regeneration

1. Juli 20212. Juli 2021 Firma BellaSenoForschung und Entwicklungabsorbable, bellaseno, bellasenos, bone, breast, cell, chhaya, clinical, fraunhofer, implant, market, patients, scaffold, senella, with

. Collaboration with Fraunhofer IZI further expanded Funding provided by Sächsische Aufbaubank BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that the Company has initiated a program on tendon and ligament reconstruction Mehr

BellaSeno Wins Prestigious German Innovation Award 2021

18. Mai 2021 Firma BellaSenoMedizintechnikabsorbable, bellaseno, bluechip, breast, chhaya, clinical, excavatum, implant, medtech, new, patients, pectus, scaffold, senella, with

BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that the Company has received the German Innovation Award from the German Design Council for its Senella® technology in the category #W2 Excellence in Business Mehr

BellaSeno and Fraunhofer Institute for Production Technology IPT Receive EUR 1.4 Million BMBF Grant

10. März 202110. März 2021 Firma BellaSenoMedizintechnikabsorbable, bellaseno, breast, cloud, fraunhofer, implant, implants, market, patients, printing, robot, robotics, scaffold, senella, with

Funding dedicated to the development of commercial-scale, fully automated additive manufacturing of resorbable medical implants First-ever industrial-scale, additive manufacturing platform of medical implants BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, and the Fraunhofer Mehr

BellaSeno Establishes GMP-Compliant High-Throughput Additive Manufacturing Facility for Resorbable Medical Implants

17. November 2020 Firma BellaSenoMedizintechnikabsorbable, bellaseno, breast, cell, chhaya, clinical, fraunhofer, implant, implants, medtech, research, scaffold, senella, therapy, with

. – Seamless transition from R&D to commercial-scale additive manufacturing – Leading-edge cleanroom, no-touch manufacturing – GMP capabilities for internal and contract manufacturing BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced the Mehr

BellaSeno Announces First-In-Human Trial of its Novel, Absorbable Soft Tissue Reconstruction Scaffold and Granting of Key U.S. Patent

21. Juli 2020 Firma BellaSenoMedizintechnikabsorbable, ades, bellaseno, breast, chhaya, clinical, endpoint, implant, implants, medtech, patients, scaffold, senella, syndrome, with

First patient with Pectus Excavatum congenital defect has undergone surgery in Australia Minimally invasive procedure and fully absorbable scaffold expected to provide for improved safety and recovery Key U.S. patent granted for the design and porosity of Senella® platform BellaSeno Mehr

BellaSeno Appoints Dr. Mohit Chhaya as Chief Executive Officer

31. März 202031. März 2020 Firma BellaSenoFirmeninternabsorbable, additive, analytics, award, bellaseno, bellasenos, breast, chhaya, clinical, implants, mba, medtech, senella, supervisory, tum

BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that co-founder and former Chief Technology Officer Dr. Mohit Chhaya, PhD, has been appointed as the Company´s Chief Executive Officer. Starting on April 1, Mehr

Autor: Firma BellaSeno